Expansions of an intronic GAA repeat reduce the expression of frataxin and cause Friedreich's ataxia (FRDA), an autosomal recessive neurodegenerative disease. Frataxin is a mitochondrial protein, and disruption of a frataxin homolog in yeast results in increased sensitivity to oxidant stress, increased mitochondrial iron and respiration deficiency. These previous data support the hypothesis that FRDA is a disease of mitochondrial oxidative stress, a hypothesis we have tested in cultured cells from FRDA patients. FRDA fibroblasts were hypersensitive to iron stress and significantly more sensitive to hydrogen peroxide than controls. The iron chelator deferoxamine rescued FRDA fibroblasts more than controls from oxidant-induced death, consistent with a role for iron in the differential kinetics of death; however, mean mitochondrial iron content in FRDA fibroblasts was increased by only 40%. Treatment of cells with the intracellular Ca 2+ chelator BAPTA-AM rescued both FRDA fibroblasts and controls from oxidant-induced death. Treatment with apoptosis inhibitors rescued FRDA but not control fibroblasts from oxidant stress, and staurosporine-induced caspase 3 activity was higher in FRDA fibroblasts, consistent with the possibility that an apoptotic step upstream of caspase 3 is activated in FRDA fibroblasts. These results demonstrate that FRDA fibroblasts are sensitive to oxidant stress, and may be a useful model in which to elucidate the FRDA mechanism and therapeutic strategies.
INTRODUCTION
Friedreich's ataxia (FRDA), the most common hereditary ataxia, is an autosomal recessive disease characterized by unsteady gait, muscle weakness of the legs, neuropathy and cardiomyopathy (1) . Degeneration of the spinal cord, mainly the posterior columns and spinocerebellar tracts, occurs in FRDA patients. The cervical region is most severely damaged along with loss of large cells in the dorsal root ganglia, followed by loss of large myelinated axons in the peripheral nerve (2) .
The genetic defect observed most frequently in FRDA patients is a GAA repeat expansion in the first intron of the gene encoding frataxin, a protein of unknown function (3) . The GAA repeat expansion appears to inhibit both gene transcription and replication (4) . While normal individuals possess 8-30 GAA repeats, FRDA patients have from 160 to >1200 copies of the GAA repeat (3, 5) . The genome of Saccharomyces cerevisiae contains a frataxin homolog, YFH1 (yeast frataxin homolog), knockout of which causes increased sensitivity to oxidative stress induced by hydrogen peroxide (H 2 O 2 ), iron and copper, and an increased level of mitochondrial iron (6, 7) . Depletion of mtDNA and a decrease in respiration were observed in ∆YFH1 cells (7, 8) . In human cells, frataxin has been localized to mitochondria (9) , and is highly expressed in heart, muscle, liver and pancreas (3, 9) . Interestingly, decreases in the activity of the mitochondrial iron-sulfur-containing proteins aconitase and respiratory chain complexes I, II and III have been observed in heart biopsies from a limited number of FRDA patients (10) , which would suggest a pathogenic role for oxidant stress, as iron-sulfur proteins are exquisitely sensitive to the accumulation of reactive oxygen species.
Studies reported here address whether human FRDA fibroblasts may be a reasonable model system in which to study the cellular effects of GAA expansion (i.e. whether the mutation confers a predisposition to cell death), and also to test in this model system potential therapeutic agents that would be expected to inhibit death induced by oxidant stress on mechanistic grounds.
RESULTS

Levels of frataxin mRNA levels are reduced in FRDA fibroblasts
Frataxin mRNA levels were measured by RT-PCR and normalized to those of an unrelated mitochondrial protein, β-MTP, the β-subunit of mitochondrial trifunctional protein. (Fig. 1a) . FRDA and control cells exhibited 81.7 ± 6.8 (95% CI) versus 93.2 ± 1.0% viability at 50 µM H 2 O 2 , and 51.6 ± 3.2% and 86.4 ± 6.2% at 100 µM H 2 O 2 , respectively.
FRDA fibroblasts were hypersensitive to iron, an element known to induce oxidative stress, relative to controls (Fig. 1b) . Control cells maintained nearly 100% viability at up to 5 mM FeCl 3 , while only 50% of the FRDA fibroblasts were viable at 1 mM FeCl 3 .
An iron chelator rescues FRDA fibroblasts preferentially from death
Deferoxamine mesylate is a specific iron chelator used in clinical practice (11) . FRDA fibroblasts (Fig. 2b ) treated with deferoxamine were rescued from H 2 O 2 -induced death to a greater extent than controls (Fig. 2a) .
One possible cause of increased sensitivity to oxidant stress in the human FRDA fibroblasts is an increased concentration of mitochondrial iron, as has been observed in the yeast knockout of the frataxin homolog (6, 7) . We did observe a small (40%) increase in mean concentration of mitochondrial iron in FRDA fibroblasts: 8.93 versus 6.36 nmol/mg in controls; however, this difference was not statistically significant (Fig. 3a) . Other experiments with three FRDA and three control lymphoblast lines gave similar results, i.e. a 30% increase in mean mitochondrial iron content, but the difference in means was not significant at the 95% confidence level (data not shown). Supplementation of tissue culture medium with uridine and pyruvate rescues growth defects resulting from mitochondrial dysfunction, presumably because the main function of mitochondria in a high-glucose tissue culture environment is to provide pyrimidines for nucleic acid synthesis (12, 13) . If frataxin expansions cause mitochondrial dysfunction, then one would expect that supplementation of tissue culture medium with uridine and pyruvate would preferentially boost the growth rate of FRDA versus control fibroblasts. Supplementation with pyruvate and uridine strongly and significantly (P < 0.005) boosted the growth rate of FRDA fibroblasts, consistent with a mitochondrial biochemical defect (Fig. 3b) .
Depletion of intracellular calcium ion rescues FRDA fibroblasts and controls from oxidant-induced death
Although the complete mechanism by which oxidant stress kills cells is not completely understood, oxidant stress often causes a rise in intracellular Ca 2+ , which may be required for cell death (14, 15) . Treatment of cells with an intracellular Ca 2+ chelator, BAPTA-AM, provided significant rescue of both control and FRDA fibroblasts from oxidant-induced death (Fig. 4) , and FRDA and control cell lines were grown in MEM + 10% FBS + 8 mM glutamine (-P, -U) or MEM + 10% FBS + 8 mM glutamine + 1 mM pyruvate + 50 mg/ml uridine (+P, +U) for 24 h, after which total cell number was determined. The mean percentage growth from five FRDA and five control fibroblasts is represented from six independent experiments. Growth in media containing pyruvate and uridine was significant, P < 0.005 for both FRDA and control fibroblasts, in comparison with media without pyruvate and uridine. Bars represent two standard errors of the mean. a b depletion of Ca 2+ from cell media also provided significant rescue (data not shown).
We previously have shown that cyclosporin A (CsA) can protect cells with mitochondrial mutations from oxidant-induced death (14) , presumably by blocking the mitochondrial permeability transition (MPT). To investigate this possibility of protection in FRDA fibroblasts, cells were pre-treated with 1 µM CsA for 30 min before addition of H 2 O 2 , and no protection was observed in FRDA nor control fibroblasts (data not shown). Recently, mitochondrial disruption has been shown to trigger the apoptotic cascade directly (16) (17) (18) (19) (20) . If mitochondrial stress in mutant FRDA fibroblasts resulted in activation of the apoptotic cascade, then one might predict that inhibitors of apoptosis should rescue FRDA fibroblasts preferentially from death. The apoptosis inhibitor z-VAD.fmk conferred significant rescue on FRDA fibroblasts, but not controls (Fig. 5a and b) . Other inhibitors of apoptosis, YVAD-CHO and DEVD-CHO, provided similar extents of rescue (data not shown). For example, at 250 µM H 2 O 2 , the addition of z-VAD.fmk increased the viability of FRDA fibroblasts from 21.0 ± 3.4 to 66.6 ± 8.8%, whereas the viability of control cells at this dose was not significantly different. z-VAD.fmk did not provide significant protection of control cells from death, consistent with the view that caspase activity is not required for death of control cells. In fact, at the 100 µM dose of H 2 O 2 , z-VAD.fmk appeared to accelerate death slightly, an unexpected result.
If intrinsic mitochondrial disruption was occurring in FRDA fibroblasts, then one might expect more activation of the central death enzyme of apoptosis, caspase 3. Death was induced with the apoptotic agent staurosporine. A significantly higher activity of caspase 3 activity was observed in FRDA versus control fibroblasts (Fig. 5c) .
DISCUSSION
The results presented above demonstrate that the GAA expansion in frataxin confers H 2 O 2 sensitivity and iron hypersensitivity on human FRDA fibroblasts. The kinetics of FRDA fibroblast death were dependent on the concentration of H 2 O 2 and iron, consistent with an oxidative stress hypothesis for FRDA. Iron is a crucial reagent in the Fenton reaction, as it can react with mitochondrially produced superoxide anion (·O 2 -) to produce toxic free radicals such as the hydroxyl radical (·OH -). Thus, consistent with the knockout yeast model ∆YFH1, the results presented here support a pathogenic role for oxidative stress in FRDA. The iron chelator deferoxamine specifically rescued FRDA and, to a lesser extent, control cells from death, consistent with a death mechanism dependent on Fenton chemistry. Although mean iron levels were slightly higher in FRDA mitochondria than in controls, the difference was not statistically significant in the two fibroblast (Fig. 3a) and three lymphoblast (data not shown) lines examined. The small difference in iron concentration may be the consequence of residual frataxin expression in FRDA fibroblasts, in contrast to the situation in knockout yeast with zero expression of YFH1. An alternative explanation is that in comparison with controls, FRDA fibroblasts either may experience intrinsically higher endogenous levels of oxidant stress or contain an oxidant-sensitive target, which would explain the sensitivity of FRDA fibroblasts to oxidants in the absence of a large difference in mitochondrial iron accumulation.
Increases in concentration of the intracellular Ca 2+ ion are known to follow oxidant stress in many cell types (15) . Chelation of intracellular Ca 2+ rescued both FRDA and control fibroblasts from death, demonstrating a requirement for Ca 2+ for oxidant-induced death, but not necessarily any difference in this Ca 2+ -dependent step in FRDA versus control fibroblasts. In contrast to our earlier results in osteosarcoma cells bearing pathogenic mitochondrial DNA mutations in which CsA provided preferential protection from death induced by oxidant stress, presumably by inhibiting the MPT (14), we observed no protection by CsA of FRDA or control fibroblasts (data not shown). The implication is that oxidative stress is not killing FRDA fibroblasts by induction of the MPT.
Presumably a common endpoint of multiple toxic stimuli to cells is activation of the apoptotic machinery, which recently has been shown to be regulated at least partially at the mitochondrial level. If the FRDA mutation conferred excess activation of the apoptotic pathway, one would predict a greater sensitivity to agents which induce cell death (i.e. Fig. 1 ), and also a greater degree of protection from cell death by apoptosis inhibitors. The staurosporine-induced caspase 3 activity was significantly higher in FRDA fibroblasts than in controls, and three known biochemical inhibitors of the apoptosis machinery provided significant protection of FRDA but not of control fibroblasts from death. These findings are consistent with the idea that the apoptotic pathway is activated preferentially in FRDA fibroblasts.
Altogether, our data suggest that FRDA may be the latest addition to the increasing list of neurodegenerative disorders caused by oxidative stress (21, 22) . The results indicate that expansions of GAA in the frataxin gene result in increased susceptibility of cells to oxidant-induced death, and thus the cells potentially could be used as a model to study the mechanism of death acceleration, which may relate to the FRDA disease process. In addition, the results demonstrate rescue from death by chelators of iron and calcium and by apoptosis inhibitors in the model system, which may suggest that antioxidant, chelation and anti-apoptotic therapy potentially could be considered for this devastating neurodegenerative disease.
MATERIALS AND METHODS
Reagents
H 2 O 2 was purchased from Fisher (Pittsburgh, PA), 1,2-bis(2-aminophenoxy)-ethane-N,N,N′,N′-tetraacetic acid tetrakis(acetoxymethyl)ester (BAPTA-AM) and deferoxamine mesylate were purchased from Sigma (St Louis, MO), z-VAD.fmk was purchased from Enzyme Systems (Livermore, CA), YVAD-CHO was purchased from Calbiochem (Cambridge, MA) and DEVD-CHO was purchased from Biomol (Plymouth Meeting, PA).
Patients, DNA analysis and cell culture conditions
All five FRDA fibroblast cell lines used in this study were from patients diagnosed with classical Friedreich's ataxia. Mean passage numbers of FRDA and control fibroblasts were 15 and 13, respectively. Analysis of the GAA repeat expansion was performed by PCR as described (23) Mean expression of FRDA fibroblasts was 33.6% of the control mean. Fibroblasts were grown in minimal essential medium (MEM; Life Technologies, Gaithersburg, MD), supplemented with 8 mM glutamine, 10% fetal bovine serum (FBS), 50 mg/ml uridine, 1 mM sodium pyruvate, 10 µg/ml insulin, 10 ng/ml epidermal growth factor (EGF), 50 ng/ml basic growth facor (bFGF), and gentamicin.
Frataxin expression analysis
RT-PCR analysis of frataxin expression was performed in the five FRDA fibroblast cell lines as well as in five control cell lines. Poly(A) + mRNA was prepared from 4.5 × 10 6 cells using the FastTrack kit (Invitrogen, Milan, Italy) following the manufacturer's instructions. cDNA was synthesized from 1 µg of poly(A) + mRNA using the Expand reverse transcriptase (Boehringer, Monza, Italy) and the 'lock-docking' protocol as previously described (24) . A frataxin RT-PCR fragment of 480 bp was amplified using the sense oligonucleotide primer FA1/2-S (5′-ACGCCCCGCCGCGCAAGTTCGAAC-3′) and the antisense primer FA5A-AS (5′-AGCATCTTTTCCGGAATAGGC-CAA-3′). As an internal control, a similar size (529 bp) fragment was amplified from the mRNA of 3-ketoacyl-CoA thiolase β-MTP (GenBank accession no. D16481) using the sense primer IMA-S (5′-ATCATGGCGGAGGAAAAGGCTCTG-3′) and the antisense primer FINE-AS (5′-AAATGGCATTGCCTAGTGT-GAGTGTTG-3′). Optimal conditions for semi-quantitative analysis of PCR products were selected, which included sampling during the log-phase of PCR and determination of the optimal amount of DNA loaded on the 2% agarose gel. Densitometric scanning of the gel was performed using a digital camera and the software Bio-Profil (Vilber-Lourmat, Paris, France). The mean of two independent experiments was used. Frataxin mRNA levels were expressed as a percentage of mRNA levels of the control transcript. The frataxin mRNA level in five FRDA cells was 0.037 ± 0.018 (95% CI) and of control cells (66LS, 269 and 305) was 0.110 ± 0.028 (95% CI).
Cell viability assay
Cell viability was determined as described (14) . Briefly, 1 × 10 5 cells were grown in MEM supplemented with 8 mM glutamine and 10% FBS 24 h prior to use. Cells were given fresh media (MEM, 8 mM glutamine and 10% FBS) before the addition of H 2 O 2 . The following reagents, with their final concentrations, were added to the cells before H 2 O 2 : 10 µM BAPTA-AM [in dimethyl sulfoxide (DMSO)], 50 µM z-VAD.fmk (in DMSO), 100 µM YVAD-CHO (in water) and 100 µM DEVD-CHO (in water). Deferoxamine mesylate (250 µM final concentration, in water) was added to cells 18 h prior to H 2 O 2 . Six hours later, cells were removed by trypsin-EDTA and resuspended in phosphatebuffered saline. Viabilty was determined by the trypan blue exclusion assay. In the case of BAPTA and z-VAD.fmk, vehicle controls with DMSO were performed. Student's t-tests were carried out to determine the significance values for both control and FRDA fibroblasts at individual doses.
Measurement of mitochondrial iron
Mitochondria were isolated from fibroblasts using the method of Rickwood et al. (25) . Mitochondrial iron was measured by atomic absorption spectroscopy as described (26) .
